Thromboembolism Prophylaxis Underused in Patients With Severe Lung Disease

Theuvenin, Frederique H.
February 2011
Pulmonary Reviews;Feb2011, Vol. 16 Issue 2, p1
The article reports that patients with severe lung disease are not maximizing therapies for preventing thromboembolism. Findings based on guidelines of the American College of Chest Physicians suggest that patients with respiratory illness are at high risk for deep-venous thrombosis (DVT) and pulmonary embolism (PE). The study also recommends that thromboembolism prophylaxis with low-molecular weight heparins be administered during hospitalization in order to prevent the occurrence of DVT and PE.


Related Articles

  • Venous thromboembolism and its prophylaxis in elective total hip arthroplasty: an international perspective. Chari, Aswin; Khokhar, Arif; Murray, David; McNally, Martin; Pandit, Hemant // Hip International;Jan-Mar2012, Vol. 22 Issue 1, p1 

    Introduction: Patients undergoing total hip arthroplasty (THA) are at high risk of developing post-operative deep vein thrombosis (DVT) or a subsequent pulmonary embolus (PE). Despite best efforts, the best prophylaxis for thromboembolic disease remains controversial. This article aims to update...

  • New guidelines recommend LMWHs.  // Drug Topics;11/20/95, Vol. 139 Issue 22, p8 

    Reports on the use of low molecular weight heparin (LMWHs) and intermittent pneumatic compression for the prevention of deep vein thrombosis (DVT) in patients undergoing knee replacement surgery, according to guidelines from the American College of Chest Physicians (ACCP).

  • Meta-analysis of low molecular weight heparin versus placebo in patients undergoing total hip replacement and post-operative morbidity and mortality since their introduction. Tasker, Andrew; Harbord, Roger; Bannister, Gordon // Hip International;Jan-Mar2010, Vol. 20 Issue 1, p64 

    Objectives: 1) To establish the clinical validity for in-patient low molecular weight heparin (LMWH) following total hip replacement (THR) through a meta-analysis of peer reviewed and published randomised placebo controlled trials (RCTs). 2) To establish whether modern peri-operative practices...

  • Heparin plus alteplase reduced morbidity more than heparin alone in submassive pulmonary embolism. Douketis, James // ACP Journal Club;Mar/Apr2003, Vol. 138 Issue 2, p35 

    Compares the application of heparin with alteplase and heparin alone in patients with acute submassive pulmonary embolism (PE) in Germany. Information on the patients included in the study; Role of thrombolysis in patients with PE; Outcomes of the study.

  • For pulmonary embolism, the edge goes to unfractionated heparin. Leibovitch, Eric // Modern Medicine;Apr98, Vol. 66 Issue 4, p65 

    Presents abstracts of studies regarding comparison of low-molecular-weight heparins with unfractionated heparin in the treatment of acute pulmonary embolism.

  • Challenging the Assumptions About Chemical Thromboprophylaxis in Knee Replacement. Leopold, Seth S. // Journal of Bone & Joint Surgery, American Volume;7/20/2011, Vol. 93-A Issue 14, pe81-1 

    The author discusses an article within the issue, "Venous Thromboembolism in Patients Having Knee Replacement and Receiving Thromboprophylaxis: A Danish Population-Based Follow-up Study," by Alma B. Pedersen and colleagues. The study looked at the incidence of hospital readmission of total knee...

  • Prevention and treatment of venous thromboembolism after major trauma. Verstraete, M. // Trauma;1999, Vol. 1 Issue 1, p39 

    In prospective studies the incidence of deep venous thrombosis, documented by venography, is between 35% and 63% in patients with major trauma. Five independent risk factors for deep vein thrombosis have been identified in these patients: older age, fracture of the femur or tibia, surgery,...

  • Fondaparinux in Pulmonary Embolism. Wertz, James // New England Journal of Medicine;2/5/2004, Vol. 350 Issue 6, p619 

    A letter to the editor is presented in response to the article "Subcutaneous fondaparinux versus intravenous unfractionated heparin in the initial treatment of pulmonary embolism," published in the October 30, 2003 issue.

  • Nove europske smjernice za plućnu emboliju -- uloga novih oralnih direktnih antikoagulansa. Zaputović, Luka // Cardiologia Croatica;Sep/Oct2014, Vol. 9 Issue 9/10, p333 

    The term venous thromboembolism (VTE) includes deep vein thrombosis (DVT) and pulmonary embolism (PE). VTE represents the third most frequent cardiovascular disease with the annual incidence of 100-200 per 100.000 inhabitants. The consequences which may be fatal or lead to chronic disease are...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics